HOPA's Practice Outcomes and Professional Benchmarking Committee (POPBC) conducted a multi-organization, voluntary survey of HOPA members between March of 2021 and January of 2022. The purpose was to better understand the landscape of oncology pharmacy at healthcare organizations throughout the United States.

The research examined: institutional description, job function, staffing, and training/certification. Data were evaluated using descriptive statistics. The analysis found that as the number of patients with cancer rises, the oncology workforce must grow. The current oncology pharmacy practice landscape can serve as a foundation for future research, metrics, and benchmarks.

This research was published in the Journal of Oncology Pharmacy Practice.


Authors: Shawn P Griffin, Jessie R Signorelli, Aubrey Lasko, Benjamin J Andrick, David Doan, Shannon Hough, Grazyna Riebandt, and Stephen Harnicar

Advocacy

HOPA and CMRignite Launch "Time to Talk Diversity in Clinical Trials" Campaign

HOPA and CMRignite have collaborated on "Time to Talk Diversity in Clinical Trials," a campaign to address the critical need for increased diversity in cancer clinical research and ensure that all patient populations are adequately represented.

Advocacy

Pharmacists & Patients Lend Their Voices to Virtual Hill Day

HOPA members, patients, and caregivers participated in a total of 80 meetings with representatives from 31 states.

Advocacy

HOPA Supports Pharmacists, Hopes for Workplace Conditions that Optimize Patient Care

The pharmacy profession is experiencing unprecedented rates of burnout and good-faith and timely talks are key to swift and satisfactory workforce negotiations.